Salmonella Typhi OmpS1 and OmpS2 porins are potent protective immunogens with adjuvant properties

Immunology

Volumn 139, Issue 4, 2013, Pages 459-471

  Moreno Eutimio, Mario A ^a,b   Tenorio Calvo, Alejandra ^a   Pastelin Palacios, Rodolfo ^c   Perez Shibayama, Christian ^c,d   Gil Cruz, Cristina ^d   López Santiago, Rubén ^e   Baeza, Isabel ^e   Fernández Mora, Marcos ^f   Bonifaz, Laura ^a   Isibasi, Armando ^a   Calva, Edmundo ^f   López Macías, Constantino ^a  

^a HOSPITAL DE ESPECIALIDADES   (Mexico)

^b HOSPITAL JUÁREZ DE MÉXICO   (Mexico)

^c UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^d CANTONAL HOSPITAL ST GALLEN   (Switzerland)

^e INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^f INSTITUTO DE BIOTECNOLOGÍA   (Mexico)

Author keywords

Adjuvants; OmpS1; OmpS2; Porins; Salmonella; Vaccines

Indexed keywords

ANTIGEN; BACTERIAL PROTEIN; CD40 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 6; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; OMPS1 PORIN; OMPS2 PORIN; OVALBUMIN; PORIN; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CELL MATURATION; CELL STRAIN HEK293; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; FEMALE; GENETIC TRANSFECTION; IMMUNIZATION; IMMUNOGENICITY; IN VITRO STUDY; IN VIVO STUDY; INFLUENZA VIRUS A H1N1; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; SALMONELLA TYPHI; T LYMPHOCYTE;

ADJUVANTS; OMPS1; OMPS2; PORINS; SALMONELLA; VACCINES;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; DENDRITIC CELLS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEK293 CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; IMMUNIZATION; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INTERLEUKIN-10; INTERLEUKIN-6; LYMPHOCYTE ACTIVATION; MACROPHAGES; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; OVALBUMIN; POLYSACCHARIDES, BACTERIAL; PORINS; SALMONELLA TYPHI; SALMONELLA VACCINES; T-LYMPHOCYTES; TIME FACTORS; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA; TYPHOID FEVER;

EID: 84879805893     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/imm.12093     Document Type: Article

References (45)

1. Crump JA, Luby SP, Mintz ED. The global burden of typhoid fever. Bull World Health Organ 2004; 82:346-53.
2. Martin LB. Vaccines for typhoid fever and other salmonelloses. Curr Opin Infect Dis 2012; 25:489-99.
3. Blanco F, Isibasi A, Raul GC, Ortiz V, Paniagua J, Arreguin C, Kumate J. Human cell mediated immunity to porins from Salmonella typhi. Scand J Infect Dis 1993; 25:73-80.
4. Calderon I, Lobos SR, Rojas HA, Palomino C, Rodriguez LH, Mora GC. Antibodies to porin antigens of Salmonella typhi induced during typhoid infection in humans. Infect Immun 1986; 52:209-12.
5. Ortiz V, Isibasi A, Garcia-Ortigoza E, Kumate J. Immunoblot detection of class-specific humoral immune response to outer membrane proteins isolated from Salmonella typhi in humans with typhoid fever. J Clin Microbiol 1989; 27:1640-5.
6. Isibasi A, Ortiz-Navarrete V, Paniagua J, Pelayo R, Gonzalez CR, Garcia JA, Kumate J. Active protection of mice against Salmonella typhi by immunization with strain-specific porins. Vaccine 1992; 10:811-3.
7. Secundino I, Lopez-Macias C, Cervantes-Barragan L et al. Salmonella porins induce a sustained, lifelong specific bactericidal antibody memory response. Immunology 2006; 117:59-70.
8. Salazar-Gonzalez RM, Maldonado-Bernal C, Ramirez-Cruz NE et al. Induction of cellular immune response and anti-Salmonella enterica serovar typhi bactericidal antibodies in healthy volunteers by immunization with a vaccine candidate against typhoid fever. Immunol Lett 2004; 93:115-22.
9. Akira S, Takeda K, Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2001; 2:675-80.
10. Medzhitov R, Janeway C Jr. The Toll receptor family and microbial recognition. Trends Microbiol 2000; 8:452-6.
11. Cervantes-Barragan L, Gil-Cruz C, Pastelin-Palacios R, Lang KS, Isibasi A, Ludewig B, Lopez-Macias C. TLR2 and TLR4 signaling shapes specific antibody responses to Salmonella typhi antigens. Eur J Immunol 2009; 39:126-35.
12. Wetzler LM. Innate immune function of the neisserial porins and the relationship to vaccine adjuvant activity. Future Microbiol 2010; 5:749-58.
13. Toussi D, Liu X, Massari P. The FomA porin from Fusobacterium nucleatum is a TLR2 agonist with immune adjuvant activity. Clin Vaccine Immunol 2012; 19:1093-101.
14. Alurkar V, Kamat R. Immunomodulatory properties of porins of some members of the family Enterobacteriaceae. Infect Immun 1997; 65:2382-8.
15. Fernandez-Mora M, Oropeza R, Puente JL, Calva E. Isolation and characterization of ompS1, a novel Salmonella typhi outer membrane protein-encoding gene. Gene 1995; 158:67-72.
16. Fernandez-Mora M, Puente JL, Calva E. OmpR and LeuO positively regulate the Salmonella enterica serovar Typhi ompS2 porin gene. J Bacteriol 2004; 186:2909-20.
17. De la Cruz MA, Calva E. The complexities of porin genetic regulation. J Mol Microbiol Biotechnol 2010; 18:24-36.
18. Flores-Valdez MA, Puente JL, Calva E. Negative osmoregulation of the Salmonella ompS1 porin gene independently of OmpR in an hns background. J Bacteriol 2003; 185:6497-506.
19. Mireles JR, Toguchi A, Harshey RM. Salmonella enterica serovar typhimurium swarming mutants with altered biofilm-forming abilities: surfactin inhibits biofilm formation. J Bacteriol 2001; 183:5848-54.
20. Rodriguez-Morales O, Fernandez-Mora M, Hernandez-Lucas I, Vazquez A, Puente JL, Calva E. Salmonella enterica serovar Typhimurium ompS1 and ompS2 mutants are attenuated for virulence in mice. Infect Immun 2006; 74:1398-402.
21. Toguchi A, Siano M, Burkart M, Harshey RM. Genetics of swarming motility in Salmonella enterica serovar typhimurium: critical role for lipopolysaccharide. J Bacteriol 2000; 182:6308-21.
22. Datsenko KA, Wanner BL. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U S A 2000; 97:6640-5.
23. Isibasi A, Ortiz V, Vargas M, Paniagua J, Gonzalez C, Moreno J, Kumate J. Protection against Salmonella typhi infection in mice after immunization with outer membrane proteins isolated from Salmonella typhi 9, 12, d, Vi. Infect Immun 1988; 56:2953-9.
24. Puente JL, Flores V, Fernandez M, Fuchs Y, Calva E. Isolation of an ompC-like outer membrane protein gene from Salmonella typhi. Gene 1987; 61:75-83.
25. low thymocytes in vivo. Science 1990; 250:1720-3.
26. Swanson JA. Phorbol esters stimulate macropinocytosis and solute flow through macrophages. J Cell Sci 1989; 94:135-42.
27. Colwell DE, Michalek SM, Briles DE, Jirillo E, McGhee JR. Monoclonal antibodies to Salmonella lipopolysaccharide: anti-O-polysaccharide antibodies protect C3H mice against challenge with virulent Salmonella typhimurium. J Immunol 1984; 133:950-7.
28. Muthukkumar S, Muthukkaruppan VR. Mechanism of protective immunity induced by porin-lipopolysaccharide against murine salmonellosis. Infect Immun 1993; 61:3017-25.
29. MacLennan CA, Gilchrist JJ, Gordon MA et al. Dysregulated humoral immunity to nontyphoidal Salmonella in HIV-infected African adults. Science 2010; 328:508-12.
30. Zinkernagel RM, Hengartner H. On immunity against infections and vaccines: credo 2004. Scand J Immunol 2004; 60:9-13.
31. Hernandez-Lucas I, Calva E. The coming of age of the LeuO regulator. Mol Microbiol 2012; 85:1026-8.
32. van RE, Everts B, Retra K et al. Combined TLR2 and TLR4 ligation in the context of bacterial or helminth extracts in human monocyte derived dendritic cells: molecular correlates for Th1/Th2 polarization. BMC Immunol 2009; 10:9.
33. Pone EJ, Xu Z, White CA, Zan H, Casali P. B cell TLRs and induction of immunoglobulin class-switch DNA recombination. Front Biosci 2012; 17:2594-615.
34. Pone EJ, Zhang J, Mai T et al. BCR-signalling synergizes with TLR-signalling for induction of AID and immunoglobulin class-switching through the non-canonical NF-κB pathway. Nat Commun 2012; 3:767.
35. Quintana FJ, Solomon A, Cohen IR, Nussbaum G. Induction of IgG3 to LPS via Toll-like receptor 4 co-stimulation. PLoS ONE 2008; 3:e3509.
36. Jin J, Samuvel DJ, Zhang X, Li Y, Lu Z, Lopes-Virella MF, Huang Y. Coactivation of TLR4 and TLR2/6 coordinates an additive augmentation on IL-6 gene transcription via p38MAPK pathway in U937 mononuclear cells. Mol Immunol 2011; 49:423-32.
37. Hirata N, Yanagawa Y, Ebihara T et al. Selective synergy in anti-inflammatory cytokine production upon cooperated signaling via TLR4 and TLR2 in murine conventional dendritic cells. Mol Immunol 2008; 45:2734-42.
38. Cucak H, Yrlid U, Reizis B, Kalinke U, Johansson-Lindbom B. Type I interferon signaling in dendritic cells stimulates the development of lymph-node-resident T follicular helper cells. Immunity 2009; 31:491-501.
39. Schmitz N, Beerli RR, Bauer M et al. Universal vaccine against influenza virus: linking TLR signaling to anti-viral protection. Eur J Immunol 2012; 42:863-9.
40. Wood JM, Major D, Heath A et al. Reproducibility of serology assays for pandemic influenza H1N1: collaborative study to evaluate a candidate WHO International Standard. Vaccine 2012; 30:210-7.
41. Lake JP, Reed ND, Ulrich JT, Varitek VA. Development of a localized hemolysis-in-gel assay for Vi antigen: characterization of the Vi-specific PFC response of nude and normal mice. Immunol Commun 1977; 6:149-65.
42. Fraser A, Paul M, Goldberg E, Acosta CJ, Leibovici L. Typhoid fever vaccines: systematic review and meta-analysis of randomised controlled trials. Vaccine 2007; 25:7848-57.
43. Marshall JL, Flores-Langarica A, Kingsley RA et al. The capsular polysaccharide vi from salmonella typhi is a B1b antigen. J Immunol 2012; 189:5527-32.
44. Gil-Cruz C, Bobat S, Marshall JL et al. The porin OmpD from nontyphoidal Salmonella is a key target for a protective B1b cell antibody response. Proc Natl Acad Sci U S A 2009; 106:9803-8.
45. Petrovsky N. Freeing vaccine adjuvants from dangerous immunological dogma. Expert Rev Vaccines 2008; 7:7-10.